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Oxidative stress is thought to be involved m the progression of human immunodeficiency virus type 1 (HIV-1)-induced disease. We examined the 
effect of superoxide (02-) on HIV-l spread in cultured human CD4’ cell lines. The 02- sigmficantly enhanced cell-to-cell transmission of HIV-l, 
although its effect on HIV-l replication was not evident, presumably due to its cytostatic activity The effect was notable on the HIV-l transmission 
from macrophages to T lymphocytes by endogenous, macrophage-generated 02-. This amphficatton was spectfically reduced to the steady-state 
level by anttoxidants, and further to the basal level by anti-CD4 anttbodies, Indicating the spectficity of O,- for enhancmg HIV-l spread by 
cell-to-cell transmisston. 
HIV-l: Superoxide: Syncytium formation: Antioxidant: AIDS 
1. INTRODUCTION 
Human immunodeficiency virus type 1 (HIV- 1) is the 
causative agent of acquired immune deficiency syn- 
drome (AIDS) [I]. AIDS is characterized by depletion 
of the CD4 subset of T lymphocytes. which results in 
selective immunodeficiency [2]. CD4 present on the sur- 
face of helper T lymphocytes and mononuclear ph- 
agocytes serves as the receptor for HIV-I infection 
through interaction with the HIV-l envelope glycopro- 
tein, gp120 [3]. It is thought that continued viral infec- 
tion of CD4+ T cells may be responsible for the progres- 
sive loss of immune function. There are two major ways 
that HIV-1 infection can spread to CD4’ cells. HIV-l 
produced from an infected cell may infect neighboring, 
uninfected cells. HIV-l infection could be transmitted 
from cell-to-cell without being exposed to the extracel- 
lular environment, as evidenced by syncytia formation 
in in vitro co-culture system. Either way, the specific 
interaction between CD4 and gp120 is responsible for 
HIV-l infection [4]. 
Recently, we showed significant amplification of su- 
peroxide (02-) generation in cells of mononuclear ph- 
agocytic lineage by HIV- 1 infection, which seemed to be 
due to HIV-l-provided cytosolic factor(s) [5]. This find- 
ing suggests a role of O?- in HIV-l-induced disease 
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progression to AIDS. In fact, several reports have sug- 
gested the involvement of oxidative stress in the disease 
progression. An indirect argument in favor of the role 
of oxidative stress in the disease progression is the con- 
sumption of glutathione, a major intracellular antioxi- 
dant, or the elevated excretion of malondialdehyde into 
the urine, reflecting increased levels of lipid peroxida- 
tion in HIV-l -infected patients [6.7]. Thus, the precise 
role of O,- seems to be important for our understanding 
of the pathogenesis of AIDS. Recently, it has been sug- 
gested that HIV-l replication is amplified by H,O, in 
the Jurkat cell system in which transcriptional activa- 
tion of NF-KB was observed [8]. In this study, we exam- 
ined the direct effect of 02- on the replication and trans- 
mission of HIV-l in cultured human CD4’ cell lines. 
The results showed that 02- could affect HIV-l spread 
by cell-to-cell transmission, although we did not identify 
a significant effect of O?- on HIV-l replication. 
2. MATERIALS AND METHODS 
2.1 Ceils and wrus 
The promonocytic cell lme U937 [9] and the T cell line MOLT-4 
clone No. 8 (MOLT-#8) [IO] were cultured m complete medium 
(RPMI-1640 supplemented with 5% fetal bovme serum). The LA1 
stram [1] was used as an HIV-l inoculum. Perststently Infected 
MOLT-#8 (MOLT-#S/LAI) was obtained by serial passage of the 
cells after infection with the LA1 stram as described previously [ 111. 
2.2. Detemon of HIV-I expressron 
To detect the HIV-l antigen expression, Indirect tmmunofluores- 
cence (IF) was performed against acetone-fixed cells as previously 
descrtbed [12]. The production of HIV-l particles was measured by 
reverse transcriptase (RT) assay as previously described [13]. 
2.3. Dlfferentration of U937 cells 
U937 cells (2.5 x lo6 cells/ml) were treated with vartous concentra- 
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Cons of phorbo! !2-myristate !3-acetate (PMA; 5-100 @ml) for 2 h 
at 37°C as described previously [5]. The cells were then washed, ad- 
justed to 5 x 10’ cells/m!, then incubated m a CO?-mcubator at 37°C 
for 10 days. 
2.4. Generation of O,- 
02- was generated by two methods. 02- was enzymatlcally gener- 
ated using various doses of xanthine oxidase and 2.5 mM hypoxan- 
thine as a substrate. 02- was also generated from differentiated U937. 
The U937 cells were differentiated by treatment with a high dose of 
PMA followed by incubation for 10 days as described above, then 
primed for O,- generation for 15 mm with a low dose of PMA (a final 
concentration of 30 pg/m!) as described previously [5]. 
2.5. O,- assa) 
02- generatlon from cells was photometrically assayed using super- 
oxide dlsmutase (SOD) mhibltable ferricytochrome c reduction as 
previously described [ 141. 
2.6. Effect of O,- on HIV-l replication 
MOLT-#8 cells (2.5 x lo6 cells/m!) were acutely infected with LA1 
at a multiplicity of infection (MOI) of 1 for 2 h at 37°C The cells were 
washed then incubated with enzymatically generate’d O,- for 30 mm. 
The cells were washed again and incubated for up to 10 days. Then, 
the cells and culture fluids were subjected to IF and RT assay, respec- 
tively, for the determmation of the HIV-l-specific antigen expression. 
2.7. Effect of O,- on HIV-1-mduced syncytla formation 
The effect of OZ- on HIV-!-induced syncytia formation was exam- 
ined in three cell systems essentially as described previously [!5]. 
Firstly, MOLT-#g/LA1 was mixed with uninfected MOLT-#8 at a 
ratio of !:9. then treated with enzymatically generated 02- for 30 mm. 
After the cells were washed and co-cultured for 24 h. the cyncytia 
number formed was calculated from the average of triplicate assays. 
Secondly, U937 cells differentiated by treatment with a high dose of 
PMA as described above, were primed for 15 mm with a low dose of 
PMA for 02- generation. The U937 cells were washed then co-cultured 
at a !:I ratio with MOLT-#8 which has been infected with HIV-1 at 
an MO1 of 1 for 2 h. After incubation for 5 days, the cyncytia number 
was similarly calculated. Thirdly. U937 cells pretreated with PMA at 
a final concentration of 100 rig/m!! at 37°C for 2 h were washed and 
then infected with HIV-I at an MO1 of 1. After adsorption for 2 h, 
the cells were agam washed and cultured for 10 days for differentia- 
tion. These HIV-!-infected, differentiated U937 cells were primed for 
15 mm with a low dose of PMA for 02- generation. The U937 cells 
were washed agam and then co-cultured with MOLT-#8 at a ratio of 
l:! for 5 days. The cyncytia number was similarly calculated. 
2.8 Blocking assays 
Two antloxldants, SOD and ceruloplasmm (CP), were used to deter- 
mine the specificity of the O,- effect on HIV-! induced syncytia forma- 
tion. These antioxidants were mixed with the cells just before OZ- 
generation m each cell system. 
2.9. Reagents 
Reagents were obtained commercially as follows: xanthine oxidase. 
hypoxanthine. and SOD from Wako Pure Chemical Industries 
(Osaka, Japan): PMA from Sigma (St. LOUIS, USA); CP from The 
Green Cross Corp. (Osaka. Japan); anti-Leu3A from Becton Dlckm- 
son Immunocytometry Systems (Mountain View. USA); FITC-conJu- 
gated rabbit anti-human IgG from Dakopatts A/S (Copenhagen. Den- 
mark), and [a-“P]dTTP (800 Cl/mmol) from DuPont-New England 
Nuclear (Boston. USA). 
3. RESULTS AND DISCUSSION 
It has been hypothesized that oxidative stress is in- 
volved in the progression of HIV-l-induced disease 
[6,7]. One explanation is the amplification of HIV-l 
Deye after infection 
Fig. 1. Effect on 02- on HIV-l replication. MOLT-#8 cells mock-infected (A-C) or acutely infected with HIV-l (D-F) were untreated CO) or treated 
with OZ- generated from 0.02 units/m! of xanthine oxidase and 2.5 mM hypoxanthme (0). and cultured for up to 10 days. (A and D) Viable ce!! 
number counted by Trypan blue exclusion. (B and E) HIV-! antigen expression m infected cells visualized by IF. (C and F) RT activity in the fluld 
of Infected cells. 
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Fig 2. Effect of enzymatlcally generated 02- on syncytia formatlon. 
The syncytla number was counted in co-culture of uninfected MOLT- 
#8 with MOLT-#g/LA1 in the absence (c) or presence of 02- which 
was generated from 0.02 units/ml of xanthine oxldase and 2.5 mM 
hypoxanthme (m). The cells were incubated without (-) or with anti- 
oxidant. SOD or CP.Just before O,- generatlon (A) In an Independent 
experiment, the cells were also untreated (-) or treated with antl- 
Leu3A. just before 01- generatlon (B). 
replication as shown by the specific activation of DNA- 
binding and the appearance in the nucleus of the tran- 
scription factor NF-KB. in Jurkat cells exposed to H,O, 
[8]. Here, we examined the effect of 02- on the replica- 
tion rate of HIV-l in the human CD4+ T cell line. 
MOLT- 8 (Fig. 1). The O,- was enzymatically generated 
using various doses of xanthine oxidase and 2.5 mM 
hypoxanthine. The results at doses of 0.02 units/ml of 
xanthine oxidase was 2.5 mM of hypoxanthine which 
generated 33 nmol/5 min of 01- were shown in Fig. 1. 
as representative, since there were no effect at lower 
doses of xanthine oxidase and cytostatic effect at this 
dose (Fig. 1A and D), whereas there was cytotoxic effect 
at higher doses. HIV-l-specific IF and RT assays 
showed rather a suppressed effect on the HIV-l replica- 
tion in infected MOLT-#8 at this dose (Fig. IE and F). 
However, this effect seems to be due to the cytostatic 
effect of O,- against infected MOLT-#8 as well as unin- 
fected MOLT-#8, as shown by their decreased cell 
growth rates in the presence of O,- (Fig. IC and D). The 
growth of the infected cells was more suppressed com- 
pared with uninfected cells (Fig. 1C and D), presumably 
due to a cytopathic effect induced by HIV- 1 replication. 
Next, we examined the effect of O,- on HIV-l-induced 
syncytia formation. 
The effect of enzymatically generated O,- on HIV-l- 
induced syncytia formation was examined by means of 
a co-culture system of MOLT-#8/LAI and uninfected 
MOLT-#8 (Fig. 2). There was significant amplification 
of syncytia formation in the co-culture in the presence 
of 02-, compared with the steadystate level in the ab- 
sence of O,-. The number of syncytia reached the maxi- 
mal levels at around 24 h incubation. In Fig. 2, the 
Fig. 3. Profiles of amplified syncytia formation by OZ- and its specific reduction by ant]-LedA. The cell system was the same as that described 
in the legend to Fig. 2. The co-cultured cells were untreated (A and C) or treated with anti-Leu3A (B and D) before exposure to (C and D) or 
without (A and B) 02-. 
184 
Volume 331, number 1,2 FEBS LETTERS September 1993 
300- B C 
0 5 20 50 100 
PMA (nglml) PMA (nglml) 
(-) + SOD + CP 
Antioxidant 
Fig. 4. Effect of exogenous Oz- from U937 on syncytta formation. Ozm generatton ability was examined in U937 cells by incubation wtth PMA 
at final concentrations of 0 to 100 @ml (A) MOLT-#8 acutely infected with HIV-1 was mixed with the same differentiated U937 as an 02- source. 
and the cyncytta number was counted (B). In an independent experiment, the cells were untreated (-) or treated with SOD or CP durmg OLm 
generatton (C). 
results using 0.02 units/ml of xanthine oxidase and 2.5 
mM hypoxanthine are shown as described in Fig. 1, 
since the amplification by 02- was dose-dependent and 
was maximal at these doses of xanthine oxidase and 
hypoxanthine. To assess the availability of O,- in our 
system, we assayed the blocking action of the antioxi- 
dants, CP and SOD. Both reduced the amplified 
syncytia formation in O,--treated cells to the steady- 
state level found in untreated cells (Fig. 2A). These 
results indicate the specificity of O,- for the effect on the 
HIV- 1 -induced syncytia formation. We then examined 
whether the amplified syncytia formed by O,- was medi- 
ated by CD&gp120 interaction, using an anti-Leu3A 
monoclonal antibody (anti-CD4). which recognizes the 
region reactive with gp120 [16]. Under the condition 
using 1 pug/ml of the monoclonal antibody which com- 
pletely blocked the steady-state syncytia formation in 
untreated cells to the basal level as shown previously 
[ 1.51, the HIV- 1 -induced syncytia formation amplified 
by 02--treatment was also completely blocked to the 
basal level (Fig. 2B). This result showed that the ampli- 
fied syncytia formation by O,- was also mediated by 
CD4. Representative profiles are shown in Fig. 3. 
We focused upon the availability of macrophage-gen- 
erating O,-. When U937 cells were differentiated into 
adherent cells by PMA at final concentrations of 5-100 
ng/ml, the cells generated O,- in a dose-dependent man- 
ner (Fig. 4A). Again, this 02- was also effective in en- 
hancing HIV- 1 -induced syncytia formation in acutely 
HIV-l-infected MOLT-#8. The number of syncytia 
reaching the maximal levels after 5 days is shown in Fig. 
4B. The period necessary for the maximum syncytia 
formation was longer than the 24 h required in co- 
cultured MOLT-#8 with persistently infected cells (Fig. 
2) since MOLT-#8 was acutely infected with cell-free 
HIV-l. The number of syncytia proportionally in- 
creased with the concentration of the PMA-induced 02- 
in U937. Similar to that shown as in Fig. 2A, antioxi- 
dants reduced the amplified syncytia formation (Fig. 
4C). 
Finally, we examined the possible amplification of 
HIV-l transmission from macrophages to T lympho- 
cytes by the 02- endogenously generated by the infected 
macrophages (Fig. 5). MOLT-#8 was co-cultured with 
the PMA-differentiated, HIV-l -infected U937 which 
were unprimed or primed with a low dose of PMA for 
O,- generation. The results showed that the efficiency 
of amplifying syncytium formation in the co-culture 
between infected U937 and uninfected MOLT-#8 (Fig. 
5) by endogenous O,- was much higher than that in the 
co-culture between infected and uninfected MOLT-#8 
by exogenous O,- from xanthine oxidase/hypoxanthine 
(Fig. 2A) or that in differentiated U937 (Fig. 4B). Sim- 
ilarly, antioxidants reduced the syncytia formation am- 
5001 
m 200 
‘Z 
0” 
5 100 
v) 
0 
(-) + SOD + CP 
Fig. 5. Effect of endogenous 02- from infected U937 on syncytia 
formation. The cyncytia number was counted in co-culture of unin- 
fected MOLT-#8 wrth differentiated U937 cells. U937 cells were pre- 
treated with 100 ng/ml of PMA and then infected with HIV-l, and then 
unprimed (0) or primed (B) with a low dose of PMA. The co-culture 
with the primed U937 cells were untreated (-) or treated with SOD 
or CP during Ozm generation. 
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plified by endogenous 02- (Fig. 5). Although U937 was 
infected 10 days prior to the co-culture, the maximum 
increase in syncytia formation was observed after the 
culture for 5 days, indicating the difficulty of the trans- 
mission from macrophage to T lymphocyte. 
In this report, we described that HIV-l spread is 
amplified during cell-to-cell transmission by O,- (Figs. 
2-5). Generally, it is believed that the spread of HIV-I 
predominantly occurs by cell-to-cell transmission. 
Therefore, the amplified generation of O,- not only by 
HIV-1 infection [5] but also by opportunistic infections 
is noteworthy for efficient HIV-l transmission. The ef- 
fect on amplified transmission was observed in acutely 
(Fig. 4B) or persistently (Fig. 2A) infected cells and 
uninfected CD4’ cells. Especially, the efficiency of the 
amplification was notable on the transmission of HIV-l 
from U937 to MOLT-#8 using endogenously generated 
O,- from the U937 (Fig. 5). This might be due to ampli- 
fied generation of 02- from U937 by HIV-l infection as 
reported previously [5]. Macrophage-tropic clones are 
important for the persistence of HIV-I infection espe- 
cially during the early asymptomatic phase and moreo- 
ver, a qualitative shift to more T-cell-tropic clones oc- 
curs along with progression of HIV-l infection [17]. It 
is of particular interest to clarify the involvement of 
endogenous O,- from macrophage in the shift from a 
macrophage-tropic to a T-cell-tropic virus population. 
Thus, our findings support the hypothesis that oxidative 
stress is involved in the progression of AIDS and may 
provide an alternative approach to therapy using anti- 
oxidant drugs. 
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